Disease Overview：Hypernatremia（HN）
Hypernatremia is a potentially life-threatening electrolyte disorder characterized by serum sodium concentration exceeding 145 mmol/L, typically resulting from net water loss exceeding sodium loss—or, less commonly, from excessive sodium intake. It frequently arises in vulnerable populations—including the elderly, critically ill patients, and those with impaired thirst mechanisms or hypothalamic dysfunction—and may manifest as lethargy, confusion, muscle twitching, seizures, or coma. Accurate diagnosis requires comprehensive assessment of volume status, urinary sodium and osmolality, plasma osmolality, and endocrine evaluation—particularly for underlying causes such as diabetes insipidus (central or nephrogenic), adrenal insufficiency, or inappropriate antidiuretic hormone secretion. Management hinges on cautious, individualized correction of free water deficit over 48–72 hours to avoid cerebral edema and osmotic demyelination syndrome.
China offers distinct advantages for hypernatremia management: leading endocrinology centers—such as Peking Union Medical College Hospital and Shanghai Ruijin Hospital—combine deep expertise in complex water-electrolyte disorders with advanced diagnostic capabilities, including dynamic pituitary function testing, high-resolution MRI for hypothalamic lesions, and real-time continuous sodium monitoring. Success rates in resolving underlying endocrine etiologies exceed 90% in tertiary referral cases, supported by multidisciplinary teams integrating endocrinology, nephrology, and critical care. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising clinical rigor or outcomes. As a dedicated medical tourism agency, we facilitate seamless international patient access—handling hospital referrals, coordinating pre-arrival diagnostics, ensuring transparent all-inclusive pricing, and providing end-to-end support from visa assistance to post-treatment follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Hypernatremia (Endocrinology Department)
Non-Surgical / Conservative Management
*Target Criteria:* Mild-to-moderate hypernatremia (serum Na⁺ 145–155 mmol/L), intact renal function, no severe neurologic impairment, outpatient-stable patients.
- •Oral Rehydration Therapy (Preferred for chronic, asymptomatic cases):
- Cost: ¥80–¥120 ($11–$17) — includes solution prep, nursing administration, and 2× daily electrolyte monitoring
- •IV Hypotonic Fluid Replacement (Moderate/severe, inpatient):
- Daily cost: ¥320–¥480 ($45–$67) — includes IV fluids, infusion pump use, nursing care, and 3× daily serum electrolytes (Na⁺, K⁺, Cl⁻, osmolality)
- •Diagnostic & Monitoring Labs (Per Episode):
- Urine osmolality & sodium: ¥120 ($17) - Endocrine workup (ADH, plasma osmolality, cortisol if suspected central diabetes insipidus): ¥360 ($50)
Procedural / Interventional Options
*Eligibility Criteria:* Severe hypernatremia (Na⁺ >155 mmol/L) with altered mental status; refractory central diabetes insipidus unresponsive to desmopressin; or iatrogenic hypernatremia requiring urgent correction under ICU supervision.
- •Continuous Renal Replacement Therapy (CRRT) — *Only for life-threatening hypernatremia with acute kidney injury or hemodynamic instability*:
- CRRT session (24 hrs, including anticoagulant, filter, dialysate): ¥2,800–¥3,600 ($390–$500) - Daily CRRT monitoring (electrolytes × 4, circuit integrity checks): ¥650 ($90)
- •Desmopressin Acetate (DDAVP) Infusion Protocol — *For confirmed central DI-related hypernatremia*:
Special/Complex Condition Management
- •Elderly (>75 yrs) or CKD Stage 4–5 patients: Requires slower correction (≤0.25 mmol/L/hr); extended ICU monitoring × 48 hrs: ¥4,200–¥5,800 ($585–$810)
- •Post-neurosurgical hypernatremia (e.g., after transsphenoidal resection): Combined endocrine–neurocritical care coordination; daily multidisciplinary rounds + MRI brain if indicated: ¥1,900–¥2,500 ($265–$350)/day
Quick Selection Guide
- •Mild, ambulatory adult (<65 yrs, no comorbidities): Oral rehydration + outpatient labs → Total: $11–$25
- •Moderate, hospitalized patient (Na⁺ 150–154 mmol/L, stable): IV hypotonic fluids + daily labs → Total/day: $45–$67
- •Severe, elderly or CKD patient (Na⁺ >155 mmol/L, confusion): ICU admission + CRRT or DDAVP protocol → Total 48-hr episode: $975–$1,300
- •Central DI confirmed post-pituitary surgery: DDAVP infusion + endocrine follow-up → Total 24-hr episode: $153–$195
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Hypernatremia Medical Vacation Packages
Curated transparent all-inclusive packages combining Hypernatremia treatment with China top medical destinations:
